Parents are forming a loose network teaching one another how to get their children off school-issued Chromebooks and iPads. THOUSAND OAKS, Calif. — Julie Frumin broke the news to her 11-year-old son ...

A low-fat vegan diet—without cutting calories or carbs—may help people with type 1 diabetes significantly reduce how much insulin they need, and how much they spend on it. In a new analysis published ...

Welcome to Stationery Week on the Strategist, where we’ve been obsessively researching and testing office supplies — everything from pens, pencils, and paper to task chairs. For more, head to our ...

The FDA has cleared the first app that integrates glucose data with multiple daily injection (MDI) insulin dosing for people with diabetes. Features include real-time glucose data, dose calculations, ...

Medtronic plans to launch the MiniMed Go app this spring. The company said the feature helps people using insulin pens with glycemic control. A retrospective analysis found the average time in range, ...

Please provide your email address to receive an email when new articles are posted on . The MiniMed Go app received FDA 510(k) clearance for people with type 1 or type 2 diabetes requiring insulin.

EXPECTING SOME FREEZING TEMPERATURES TO START ROLLING IN SCOTT. I FEEL LIKE THIS HAS TO BE THE BUZZ AT EVERY BREAK ROOM AT WORK THIS WEEK. HAVE YOU HEARD ABOUT THE COLD WEATHER THAT’S COMING? LOOK AT ...

Pharmacy chain CVS will pay $37.8 million for dispensing and billing health care plans including the military’s Tricare for more insulin than was prescribed for the pharmacy’s diabetic customers, ...

CVS has agreed to pay almost $38 million to settle allegations that its pharmacies overcharged the government for insulin pens over a decade, putting to bed a Department of Justice lawsuit and several ...

CVS Health (CVS) has reached a settlement with the U.S. government, requiring the company to pay $37.76M to resolve claims that it overbilled government healthcare programs for insulin pens. The ...

NEW YORK, Dec 2 (Reuters) - CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained improper reimbursements from Medicare, ‌Medicaid ...

CVS Health agreed to pay $37.76 million to settle allegations that it dispensed too many insulin pens to patients and improperly billed federal healthcare programs for those insulin prescriptions. The ...